Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1.

Espinoza-Derout J, Wagner M, Salciccioli L, Lazar JM, Bhaduri S, Mascareno E, Chaqour B, Siddiqui MA.

Circ Res. 2009 Jun 19;104(12):1347-54. doi: 10.1161/CIRCRESAHA.108.191726. Epub 2009 May 14.

2.

Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.

Cho S, Schroeder S, Kaehlcke K, Kwon HS, Pedal A, Herker E, Schnoelzer M, Ott M.

EMBO J. 2009 May 20;28(10):1407-17. doi: 10.1038/emboj.2009.99. Epub 2009 Apr 23.

3.

HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.

Ogba N, Chaplin LJ, Doughman YQ, Fujinaga K, Montano MM.

Cancer Res. 2008 Sep 1;68(17):7015-24. doi: 10.1158/0008-5472.CAN-08-0814.

4.

The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Nojima M, Huang Y, Tyagi M, Kao HY, Fujinaga K.

J Mol Biol. 2008 Oct 3;382(2):275-87. doi: 10.1016/j.jmb.2008.07.017. Epub 2008 Jul 16.

5.

Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.

Sabò A, Lusic M, Cereseto A, Giacca M.

Mol Cell Biol. 2008 Apr;28(7):2201-12. doi: 10.1128/MCB.01557-07. Epub 2008 Feb 4.

6.

Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

Fu J, Yoon HG, Qin J, Wong J.

Mol Cell Biol. 2007 Jul;27(13):4641-51. Epub 2007 Apr 23.

7.

Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat.

Schulte A, Czudnochowski N, Barboric M, Schönichen A, Blazek D, Peterlin BM, Geyer M.

J Biol Chem. 2005 Jul 1;280(26):24968-77. Epub 2005 Apr 25.

8.

Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.

Michels AA, Fraldi A, Li Q, Adamson TE, Bonnet F, Nguyen VT, Sedore SC, Price JP, Price DH, Lania L, Bensaude O.

EMBO J. 2004 Jul 7;23(13):2608-19. Epub 2004 Jun 17.

10.

MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis.

Mal A, Harter ML.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1735-9. Epub 2003 Feb 10.

11.

Structure, expression, and functional characterization of the mouse CLP-1 gene.

Huang F, Wagner M, Siddiqui MA.

Gene. 2002 Jun 12;292(1-2):245-59.

PMID:
12119119
12.

Activation of MyoD-dependent transcription by cdk9/cyclin T2.

Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL, Giordano A.

Oncogene. 2002 Jun 13;21(26):4137-48.

13.

Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.

Bergstrom DA, Penn BH, Strand A, Perry RL, Rudnicki MA, Tapscott SJ.

Mol Cell. 2002 Mar;9(3):587-600.

14.

7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Nguyen VT, Kiss T, Michels AA, Bensaude O.

Nature. 2001 Nov 15;414(6861):322-5.

PMID:
11713533
15.

The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Yang Z, Zhu Q, Luo K, Zhou Q.

Nature. 2001 Nov 15;414(6861):317-22.

PMID:
11713532
16.

Control of muscle development by dueling HATs and HDACs.

McKinsey TA, Zhang CL, Olson EN.

Curr Opin Genet Dev. 2001 Oct;11(5):497-504. Review.

PMID:
11532390
17.
18.
19.

P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Price DH.

Mol Cell Biol. 2000 Apr;20(8):2629-34. Review. No abstract available.

20.

The molecular regulation of myogenesis.

Sabourin LA, Rudnicki MA.

Clin Genet. 2000 Jan;57(1):16-25. Review.

PMID:
10733231

Supplemental Content

Support Center